Hostname: page-component-74656f9884-6grmk Total loading time: 0 Render date: 2026-11-06T08:59:22.790Z Has data issue: false hasContentIssue false

Management of fetal ductus arteriosus constriction with Digoxin and oxygen therapy

Published online by Cambridge University Press:  03 July 2020

Alina Z. Naqvi
Affiliation:
Virginia Commonwealth University School of Medicine, Richmond, VA, USA
Susan M. Lanni
Affiliation:
Division of Maternal Fetal Medicine, Department of OB/GYN, Virginia Commonwealth University, Richmond, VA, USA
Joanna B. Rosenthal*
Affiliation:
Division of Pediatric Cardiology, Department of Pediatrics, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, VA, USA
*
Address for correspondence: Joanna B. Rosenthal, MD, Children’s Pavilion, 1000 East Broad Street, Office #5-342, Richmond, VA23219, USA. Tel: (804) 628-4787; Fax: (804) 628-5858. E-mail: Joanna.Rosenthal@vcuhealth.org
Rights & Permissions [Opens in a new window]

Abstract

Constriction of the fetal ductus arteriosus is rare and usually attributed to medications or CHD. We describe a 24-year-old multigravida at 33 weeks 5 days gestation with echocardiographic findings of severe ductal constriction, a dilated, hypertrophied and hypocontractile right ventricle, and severe tricuspid regurgitation following BC powder® use. Treatment with Digoxin and oxygen resulted in a progressive 71% reduction in peak systolic ductal gradient, improved right ventricular function, and decreased tricuspid regurgitation.

Information

Type
Brief Report
Copyright
© The Author(s), 2020. Published by Cambridge University Press
Figure 0

Figure 1. Sagittal image demonstrating the constricted ductus arteriosus.

Figure 1

Figure 2. Continuous wave Doppler of the ductus arteriosus showing increased peak systolic and end-diastolic velocities at 33 weeks 5 days gestation.